Major Rating Factors:
Fair long-term capitalization index (3.0 on a scale of 0 to 10) based on weak current risk adjusted capital (moderate loss scenarios), although results have slipped from the good range during the last year. A history of deficient reserves (1.4) that places pressure on both capital and profits. In 2024 and 2025 the one year reserve development was 41.6% and 87.1% deficient respectively. Fair profitability index (3.8) with operating losses during 2025.
Other Rating Factors:
Fair liquidity (4.4) as cash resources may not be adequate to cover a spike in claims. Fair overall results on stability tests (3.5) including excessive premium growth, weak risk adjusted capital in prior years and lack of operational experience. The largest net exposure for one risk is high at 4.3% of capital.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
E - Lack of operating experience.
G - Fast asset or premium growth.
Principal Lines of Business:
Med mal (90.0%), other (10.0%)
Licensed in:
AL
Principal Investments:
Investment grade bonds (48.1%), cash (12.5%), common stock (4.7%), non investment grade bonds (4.2%), other (30.4%)
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
1605 Main Street
Sarasota, FL 34236
Sarasota, FL 34236
Phone Number
(800) 226-0793
NAIC Number
16957
Website
Largest Affiliates
There are no affiliate to display.